The biological background of BRCA1/2 [4] and different pathological aspects of BRCA1-associated tumours support the hypothesis that patients carrying a BRCA1 and/or BRCA2 mutation might have a worse breast cancer prognosis compared to non-carriers. The gene discussed is BRCA1; the disease is breast cancer.